Timothy F. Nelson
Partner at Skadden Arps Slate Meagher & Flom
Lawyer
Boston
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Expertise (38)
Key Relationships
Sort
Select Income Reit
Government Properties Income Trust
value n/a
17 dealmakers
Red Hat
Ibm Corporation
£25,361m
95 dealmakers
Kite Pharma
Gilead Sciences
£9,302m
24 dealmakers
Express Scripts Holding Co
Cigna Corporation
£48,675m
65 dealmakers
SIRIUSDECISIONS
Forrester Research
£190m
14 dealmakers
Clementia Pharmaceuticals
IPSEN
£995m
41 dealmakers
Semma Therapeutics
Vertex Pharmaceuticals
£785m
26 dealmakers
Carbonite
OPENTEXT
£1,110m
47 dealmakers
Stemline Therapeutics
Menarini Group
£541m
44 dealmakers
Montage Resources
Southwestern Energy Company
£156m
43 dealmakers
Cersci Therapeutics
Acadia Pharmaceuticals
£717m
20 dealmakers
Akcea Therapeutics
Ionis Pharmaceuticals
£334m
36 dealmakers
Information Builders
Tibco Software
16 dealmakers
Boston Dynamics
Hyundai Motor Group
£695m
34 dealmakers
ZENETEX
Vectrus
£82m
National Holdings
B. Riley Financial
Creditsights
Fitch Group
Pandion Therapeutics
Merck & Co
£1,308m
28 dealmakers
Tremont Mortgage Trust
Rmr Mortgage Trust
£129m
STRONGBRIDGE
Xeris Pharmaceuticals
£188m
53 dealmakers
Indigo Natural Resources
£1,902m
45 dealmakers
DICERNA
Novo Nordisk
£2,452m
23 dealmakers
BOTTOMLINE
Thoma Bravo
£1,956m
30 dealmakers
Verso Corporation
BILLERUDKORSNAS
£623m
39 dealmakers
The Vertex Company
£1,587m
21 dealmakers
Antares Pharma
HALOZYME
£737m
59 dealmakers
VIACYTE
£265m
42 dealmakers
Aerie Pharmaceuticals
Alcon
£650m
58 dealmakers
Bellus Health
Glaxosmithkline
£1,614m
Iveric Bio
Astellas Pharma
£4,693m
22 dealmakers
Cti Biopharma
Swedish Orphan Biovitrum (sobi)
£1,347m
76 dealmakers
Intercept Pharmaceuticals
Alfasigma
£649m
31 dealmakers
Point Biopharma
Eli Lilly And Company
£1,152m
40 dealmakers
Mirati Therapeutics
Bristol Myers Squibb Company
£3,840m
54 dealmakers
ENGAGESMART
Vista Equity Partners
£3,288m
48 dealmakers
Ambrx
Johnson & Johnson
£1,493m
38 dealmakers
Morphosys
Novartis
£2,309m
100 dealmakers
Alpine Immune Sciences
£3,867m